As per Fortune Business Insights, the North America “Orphan Drugs Market” was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan drugs. Governments in North America are increasingly spending on research and development (R&D) of orphan drugs and technologies. According to the report, the global orphan drugs market was valued at US$ 125000 Mn in 2017 and is anticipated to reach US$ 294000 Mn by 2025. The report also stated that the market would exhibit a remarkable CAGR of 11.4% during the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/orphan-drugs-market-100088
Leading Players operating in the Orphan Drugs Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Bayer AG
Hoffmann-La Roche Ltd.
Alexion Pharmaceuticals Inc.
Novo Nordisk A/S
Novartis AG
Bristol-Myers Squibb Company
AstraZeneca Plc.
Daiichi Sankyo Company Limited
GlaxoSmithKline Plc.
Amgen Inc.
Detailed Table of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Trends
Key Insights
Prevalence of major orphan disease, by key countries
Pipeline review for orphan drugs
Technological Developments
Healthcare spending for key countries – 2017
Global Orphan Drugs Market Analysis, Insights and Forecast, 2014-2025
Key Findings / Summary
Market Analysis, Insights and Forecast – By Therapy Area
Oncology
Hematology
2.3 Neurology
Endocrinology
Cardiovascular
Respiratory
Immunotherapy
Others
Market Analysis, Insights and Forecast – By Drug Type
Biologics
Non-Biologics
Market Analysis, Insights and Forecast – By Distribution Channels
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
Market Analysis, Insights and Forecast – By Geography
North America
Europe
Asia Pacific
Rest of the World
TOC Continued…